| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
101,000,000 |
| Market
Cap: |
797.90(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.7528 - $16.06 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 9.5 |
| Insider 3/6 Months : 10.1 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Adverum Biotechnologies is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Co.'s primary product candidate, ADVM-022, is a single, in-office intravitreal (IVT) injection gene therapy product. ADVM-022 is being developed for the treatment of patients with wet age-related macular degeneration who are responsive to anti-vascular endothelial growth factor therapy. Co.'s second product candidate, ADVM-062 (AAV.7m8-L-opsin), is a gene therapy product candidate being developed to deliver a functional copy of the OPN1LW gene to the foveal cones of patients suffering from blue cone monochromacy via a single IVT injection.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
230,000 |
330,000 |
350,000 |
| Total Buy Value |
$0 |
$310,500 |
$455,990 |
$472,790 |
| Total People Bought |
0 |
2 |
3 |
4 |
| Total Buy Transactions |
0 |
2 |
3 |
4 |
| Total Shares Sold |
0 |
0 |
6,201 |
140,082 |
| Total Sell Value |
$0 |
$0 |
$9,429 |
$134,803 |
| Total People Sold |
0 |
0 |
1 |
5 |
| Total Sell Transactions |
0 |
0 |
1 |
9 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gasmi Mehdi |
Director |
– • – |
2020-02-12 |
4/A |
AS |
$15.07 |
$150,690 |
D/D |
(10,000) |
274,442 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-12 |
4/A |
OE |
$4.80 |
$48,000 |
D/D |
10,000 |
284,442 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-12 |
4/A |
D |
$11.33 |
$589,876 |
D/D |
(46,976) |
274,442 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-12 |
4 |
AS |
$15.07 |
$150,690 |
D/D |
(10,000) |
258,979 |
|
70% |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-12 |
4 |
OE |
$4.80 |
$48,000 |
D/D |
10,000 |
268,979 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-12 |
4 |
D |
$11.33 |
$589,525 |
D/D |
(46,945) |
258,979 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2020-02-09 |
4/A |
D |
$10.24 |
$112,486 |
D/D |
(10,985) |
139,235 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-09 |
4/A |
D |
$10.24 |
$158,659 |
D/D |
(15,494) |
274,473 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-02-09 |
4 |
D |
$10.24 |
$118,282 |
D/D |
(11,551) |
309,867 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2020-02-09 |
4 |
D |
$10.24 |
$114,842 |
D/D |
(11,215) |
139,005 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2020-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
321,418 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2019-12-23 |
4/A |
AS |
$10.72 |
$428,800 |
D/D |
(40,000) |
150,220 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2019-12-23 |
4 |
AS |
$10.72 |
$428,800 |
D/D |
(40,000) |
228,496 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2019-06-15 |
4 |
D |
$10.82 |
$474,479 |
D/D |
(43,852) |
190,220 |
|
- |
|
| Scopa James Paul |
Director |
– • – |
2019-05-06 |
4 |
B |
$6.71 |
$134,200 |
I/I |
20,000 |
20,000 |
2.1 |
- |
|
| Gasmi Mehdi |
Director |
– • – |
2019-04-21 |
4 |
D |
$5.98 |
$3,522 |
D/D |
(589) |
321,418 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2019-02-12 |
4 |
D |
$3.55 |
$37,815 |
D/D |
(10,652) |
322,007 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2019-02-09 |
4 |
D |
$3.33 |
$41,955 |
D/D |
(12,599) |
332,659 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2019-02-09 |
4 |
D |
$3.33 |
$27,226 |
D/D |
(8,176) |
234,072 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2018-06-15 |
4/A |
A |
$0.00 |
$0 |
D/D |
88,496 |
345,258 |
|
- |
|
| Patterson Leone D |
CEO, President and Director |
• • – |
2018-06-15 |
4 |
D |
$5.55 |
$47,980 |
D/D |
(8,645) |
242,248 |
|
- |
|
| Gasmi Mehdi |
Chief Science & Tech Officer |
• – – |
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
387,031 |
|
- |
|
| Cheng Jennifer C. |
General Counsel |
• – – |
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
11,150 |
118,863 |
|
- |
|
| Patterson Leone D |
SVP, CFO, Interim Pres and CEO |
• – – |
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
88,496 |
268,496 |
|
- |
|
| Gasmi Mehdi |
Director |
– • – |
2018-04-21 |
4 |
D |
$6.30 |
$3,812 |
D/D |
(605) |
247,762 |
|
- |
|
266 Records found
|
|
Page 4 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.04 (0.51%) 
